CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

Cancer Epidemiology Biomarkers & Prevention 16, 1863-1873, September 1, 2007. doi: 10.1158/1055-9965.EPI-07-0033
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v16,p2519)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pesch, B.
Right arrow Articles by Brüning, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pesch, B.
Right arrow Articles by Brüning, T.

Dose-Response Modeling of Occupational Exposure to Polycyclic Aromatic Hydrocarbons with Biomarkers of Exposure and Effect

Beate Pesch1, Martin Kappler1, Kurt Straif3, Boleslaw Marczynski1, Ralf Preuss4, Bernd Roßbach4,5, Hans-Peter Rihs1, Tobias Weiss1, Sylvia Rabstein1, Christiane Pierl1, Michael Scherenberg6, Ansgar Adams7, Heiko Udo Käfferlein1, Jürgen Angerer4, Michael Wilhelm2, Albrecht Seidel8 and Thomas Brüning1

1 BGFA Forschungsinstitut für Arbeitsmedizin der Deatschen Gesetzlichen Unfallversicherung and 2 Abteilung für Hygiene, Sozial- und Umweltmedizin, Ruhr-Universität Bochum, Bochum, Germany; 3 IARC, Lyon, France; 4 Institut und Poliklinik für Arbeits-, Sozial- und Umweltmedizin, Friedrich-Alexander Universität Erlangen, Erlangen, Germany; 5 Institut für Arbeits-, Sozial- und Umweltmedizin, Johann-Gutenberg-Universität, Mainz, Germany; 6 Arbeitsmedizinischer Dienst der BG Bau, Oberhausen, Germany; 7 BAD Gesundheitsvorsorge und Sicherheitstechnik GmbH, Koblenz, Germany; and 8 Biochemisches Institut für Umweltcarcinogene, Grosshansdorf, Germany

Requests for reprints: Beate Pesch, BGFA Forschungsinstitut für Arbeitsmedizin der Deatschen Gesetzlichen Unfallversicherung, Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany. Phone: 49-234-302-4536; Fax: 49-234-302-4505. E-mail: pesch{at}bgfa.de

In regulatory toxicology, the dose-response relationship between occupational exposure and biomarkers is of importance in setting threshold values. We analyzed the relationships between occupational exposure to polycyclic aromatic hydrocarbons (PAH) and various biomarkers of internal exposure and DNA damage with data from 284 highly exposed male workers. Personal exposure to phenanthrene and other PAHs was measured during shift and correlated with the sum of 1–, 2+9–, 3–, and 4-hydroxyphenanthrenes in post-shift urine. PAHs and hydroxyphenanthrenes were associated with DNA damage assessed in WBC as 8-oxo-7,8-dihydro-2'-deoxyguanosine/106 dGuo and strand breaks by Comet assay as Olive tail moment. Hydroxyphenanthrenes correlated with phenanthrene (Spearman rs = 0.70; P < 0.0001). No correlations could be found between strand breaks and exposure (rs = 0.01, P < 0.0001 for PAHs; rs = –0.03, P = 0.68 for hydroxyphenanthrenes). Correlations with 8-oxo-7,8-dihydro-2'-deoxyguanosine/106 dGuo were weakly negative (rs = –0.22, P = 0.004 for PAHs) or flat (rs = –0.08, P = 0.31 for hydroxyphenanthrenes). Linear splines were applied to assess the relationships between the log-transformed variables. All regression models were adjusted for smoking and type of industry. For hydroxyphenanthrenes, 51.7% of the variance could be explained by phenanthrene and other predictors. Up to 0.77 µg/m3 phenanthrene, no association could be found with hydroxyphenanthrenes. Above that point, hydroxyphenanthrenes increased by a factor of 1.47 under a doubling of phenanthrene exposure (slope, 0.56; 95% confidence interval, 0.47-0.64). Hydroxyphenanthrenes may be recommended as biomarker of occupational PAH exposure, whereas biomarkers of DNA damage in blood did not show a dose-response relation to PAH exposure. (Cancer Epidemiol Biomarkers Prev 2007;16(9):1863–73)




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page

Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2519 - 2519.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2007 by the American Association for Cancer Research.